ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 6, 2013, Pages 1064-1073

  Mao, Jun ^a   Song, Bo ^a   Shi, Yu ^b   Wang, Bo ^a   Fan, Shujun ^a   Yu, Xiaotang ^a   Tang, Jianwu ^a   Li, Lianhong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Notch1 Breast cancer stem cell Paclitaxel Drug resistance ABCG2

Indexed keywords

I KAPPA B; NOTCH1 RECEPTOR; PACLITAXEL; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR HES 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER STEM CELL; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; MOUSE; NONHUMAN; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NF-KAPPA B; PACLITAXEL; RECEPTOR, NOTCH1; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 84875961219     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.02.022     Document Type: Article

References (44)

1. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proceedings of the National Academy of Sciences 100 2003 3983 3988
2. P. Andersen, H. Uosaki, L.T. Shenje, and C. Kwon Non-canonical Notch signaling: emerging role and mechanism Trends in Cell Biology 22 2012 257 265
3. S. Bhattacharya, A. Das, K. Mallya, and I. Ahmad Maintenance of retinal stem cells by Abcg2 is regulated by notch signaling Journal of Cell Science 120 2007 2652 2662
4. C. Chen, J.E. Chin, K. Ueda, D.P. Clark, I. Pastan, M. Gottesman, and I. Roninson Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) Cell 47 1986 381 389
5. C. Cheng, Z. Liu, H. Zhang, J. Xie, X. Chen, and X. Zhao Enhancing chemosensitivity in ABCB1-and ABCG2-overexpressing cells and cancer stem-like cells by an aurora kinase inhibitor CCT129202 Molecular Pharmaceutics 9 2012 1971 1982
6. T.P. Dang Notch, apoptosis and cancer Advances in Experimental Medicine and Biology 727 2012 199 209
7. M. Dean, T. Fojo, and S. Bates Tumour stem cells and drug resistance Nature Reviews Cancer 5 2005 275 284
8. M. Diehn, and M.F. Clarke Cancer stem cells and radiotherapy: new insights into tumor radioresistance Journal of the National Cancer Institute 98 2006 1755 1757
9. V.S. Donnenberg, and A.D. Donnenberg Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis Journal of Clinical Pharmacology 45 2005 872 877
10. G. Dontu, D. El-Ashry, and M.S. Wicha Breast cancer, stem/progenitor cells and the estrogen receptor Trends in Endocrinology and Metabolism: TEM 15 2004 193 197
11. G. Dontu, and M.S. Wicha Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia Journal of Mammary Gland Biology and Neoplasia 10 2005 75 86
12. U.M. Fiuza, and A.M. Arias Cell and molecular biology of Notch Journal of Endocrinology 194 2007 459 474
13. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, and M. Brown ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
14. M.M. Gottesman, D. LudwigJ. Xia, and G. Szakacs Defeating drug resistance in cancer Discovery Medicine 6 2009 18 23
15. A. Haimeur, G. Conseil, R. Deeley, and S. Cole The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation Current Drug Metabolism 5 2004 21 53
16. T. Hatschek, L. Carlsson, Z. Einbeigi, E. Lidbrink, B. Linderholm, and B. Lindh Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial Breast Cancer Research and Treatment 131 2012 939 947
17. B.Y. Karlan, A.M. Oza, G.E. Richardson, D.M. Provencher, V.L. Hansen, and M. Buck Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer Journal of Clinical Oncology 30 2012 362 371
18. J.H. Kim, Y.S. Kim, S.W. Kim, J.H. Park, K. Kim, and K.W. Choi Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel Journal of Controlled Release 111 2006 228 234
19. R.A. Kovall Structures of CSL, Notch and mastermind proteins: piecing together an active transcription complex Current Opinion in Structural Biology 17 2007 117 127
20. J. Kucharczak, M.J. Simmons, Y. Fan, and C. Gélinas To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis Oncogene 22 2003 8961 8982
21. X. Li, M.T. Lewis, J. Huang, C. Gutierrez, C.K. Osborne, and M.F. Wu Intrinsic resistance of tumourigenic breast cancer cells to chemotherapy Journal of the National Cancer Institute 100 2008 672 679
22. M.W. Mayo, J.L. Norris, and A.S. Baldwin Ras regulation of NF-kB and apoptosis Methods in Enzymology 333 2001 73 87
23. C.S. Mitsiades, N. Mitsiades, V. Poulaki, R. Schlossman, M. Akiyama, and D. Chauhan Activation of NF-kB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications Oncogene 21 2002 5673 5683
24. S.K. Mungamuri, X.H. Yang, A.D. Thor, and K. Somasundaram Survival signaling by Notch1: mammalian target of rapamycin (mTOR) dependent inhibition of p53 Cancer Research 66 2006 4715 4724
25. A. Pannuti, K. Foreman, P. Rizzo, C. Osipo, T. Golde, and B. Osborne Targeting Notch to target cancer stem cells Clinical Cancer Research 16 2010 3141 3152
26. D.C. Park, S.G. Yeo, M.R. Wilson, J.J. Yerbury, J. Kwong, and W.R. Welch Clusterin interacts with paclitaxel and confer paclitaxel resistance in ovarian cancer Neoplasia 10 2008 964 972
27. L. Patrawala, T. Calhoun, R. Schneider-Broussard, H. Li, B. Bhatia, and S. Tang Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 2006 1696 1708
28. L. Patrawala, T. Calhoun, R. Schneider-Broussard, J. Zhou, K. Claypool, and D.G. Tang Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic Cancer Research 65 2005 6207 6219
29. T.M. Phillips, W.H. McBride, and F. Pajonk The response of CD24-/low/CD44+ breast cancer initiating cells to radiation Journal of the National Cancer Institute 98 2006 1777 1785
30. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, and D. Coradini Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Research 65 2005 5506 5511
31. B.W. Purow, R.M. Haque, M.W. Noel, Q. Su, M.J. Burdick, and J. Lee Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation Cancer Research 65 2005 2353 2363
32. T. Reya, and H. Clevers Wnt signalling in stem cells and cancer Nature 434 2005 843 850
33. J.A. Seamon, C.A. Rugg, S. Emanuel, A.M. Calcagno, S.V. Ambudkar, and S.A. Middleton Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor Molecular Cancer Therapeutics 5 2006 2459 2467
34. N. Shafee, C.R. Smith, S. Wei, Y. Kim, G.B. Mills, and G.N. Hortobagyi Cancer stem cells contribute to cisplatin resistance in Brca1/p53 mediated mouse mammary tumors Cancer Research 68 2008 3243 3250
35. B. Song, Y. Wang, M.A. Titmus, G. Botchkina, A. Formentini, and M. Kornmann Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells Molecular Cancer 9 2010 96
36. T. Vilimas, J. Mascarenhas, T. Palomero, M. Mandal, S. Buonamici, and F. Meng Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia Nature Medicine 13 2006 70 77
37. Z. Wang, Y. Zhang, Y. Li, S. Banerjee, Y. Li, and F. Sarkar Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells Molecular Cancer Therapeutics 5 2006 483 493
38. Z. Wang, Y. Li, S. Banerjee, D. Kong, A. Ahmad, and V. Nogueira Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-κB signaling pathways Journal of Cellular Biochemistry 109 2010 726 736
39. F. Wu, A. Stutzman, and Y.Y. Mo Notch signaling and its role in breast cancer Frontiers in Bioscience 12 2007 4370 4383
40. L. Yin, O.C. Velazquez, and Z.J. Liu Notch signaling: emerging molecular targets for cancer therapy Biochemical Pharmacology 80 2010 690 701
41. F. Yu, H. Yao, P. Zhu, X. Zhang, Q. Pan, and C. Gong Let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131 2007 1109 1123
42. S. Zang, Ch. Ji, X. Qu, X. Dong, D. Ma, and J. Ye A study on Notch signaling in human breast cancer Neoplasma 54 2007 304 310
43. S. Zang, C. Feng, J.J. Dai, D.M. Guo, W. Tse, and X. Qu RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer Oncology Reports 23 2010 893 899
44. J. Zhu, D.B. Sharma, S.W. Gray, A.B. Chen, J.C. Weeks, and D. Schrag Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA: The Journal of the American Medical Association 307 2012 1593 1601